FY2024 EPS Estimates for AptarGroup Raised by Zacks Research

AptarGroup, Inc. (NYSE:ATR) – Investment analysts at Zacks Research upped their FY2024 earnings per share (EPS) estimates for shares of AptarGroup in a report issued on Thursday, November 7th. Zacks Research analyst M. Das now expects that the industrial products company will post earnings of $5.37 per share for the year, up from their prior estimate of $5.32. The consensus estimate for AptarGroup’s current full-year earnings is $5.38 per share. Zacks Research also issued estimates for AptarGroup’s Q4 2024 earnings at $1.25 EPS, Q2 2025 earnings at $1.51 EPS, Q3 2025 earnings at $1.63 EPS, Q4 2025 earnings at $1.46 EPS, FY2025 earnings at $5.95 EPS, Q2 2026 earnings at $1.68 EPS, Q3 2026 earnings at $1.71 EPS and FY2026 earnings at $6.50 EPS.

A number of other brokerages also recently weighed in on ATR. Wells Fargo & Company boosted their price target on AptarGroup from $168.00 to $185.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Robert W. Baird boosted their price target on AptarGroup from $170.00 to $185.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Jefferies Financial Group upgraded AptarGroup from a “hold” rating to a “buy” rating and boosted their price target for the company from $155.00 to $215.00 in a report on Monday, October 14th. Finally, Dbs Bank raised AptarGroup from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 16th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, AptarGroup has a consensus rating of “Buy” and a consensus price target of $195.00.

AptarGroup Price Performance

Shares of NYSE ATR opened at $175.67 on Monday. AptarGroup has a twelve month low of $122.29 and a twelve month high of $178.03. The company has a current ratio of 1.62, a quick ratio of 1.15 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $11.69 billion, a price-to-earnings ratio of 35.45, a price-to-earnings-growth ratio of 3.02 and a beta of 0.57. The business has a 50 day simple moving average of $161.48 and a 200-day simple moving average of $151.52.

AptarGroup Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 14th. Stockholders of record on Thursday, October 24th will be given a dividend of $0.45 per share. The ex-dividend date is Thursday, October 24th. This represents a $1.80 annualized dividend and a dividend yield of 1.02%. AptarGroup’s dividend payout ratio is presently 36.14%.

AptarGroup declared that its Board of Directors has initiated a stock repurchase plan on Thursday, October 10th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the industrial products company to purchase up to 4.7% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its shares are undervalued.

Insider Buying and Selling

In related news, CEO Stephan B. Tanda sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $169.60, for a total value of $5,088,000.00. Following the sale, the chief executive officer now directly owns 174,118 shares in the company, valued at $29,530,412.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Hedi Tlili sold 1,375 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $152.54, for a total value of $209,742.50. Following the sale, the insider now directly owns 9,379 shares in the company, valued at $1,430,672.66. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Stephan B. Tanda sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $169.60, for a total value of $5,088,000.00. Following the completion of the sale, the chief executive officer now owns 174,118 shares in the company, valued at approximately $29,530,412.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,735 shares of company stock valued at $7,285,268 in the last three months. 1.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On AptarGroup

Several hedge funds have recently modified their holdings of ATR. Capital Performance Advisors LLP acquired a new position in shares of AptarGroup during the 3rd quarter valued at $25,000. Blue Trust Inc. increased its position in shares of AptarGroup by 281.0% during the 2nd quarter. Blue Trust Inc. now owns 240 shares of the industrial products company’s stock valued at $35,000 after purchasing an additional 177 shares during the period. UMB Bank n.a. increased its position in shares of AptarGroup by 446.5% during the 3rd quarter. UMB Bank n.a. now owns 235 shares of the industrial products company’s stock valued at $38,000 after purchasing an additional 192 shares during the period. Gradient Investments LLC acquired a new position in shares of AptarGroup during the 2nd quarter valued at $40,000. Finally, Versant Capital Management Inc increased its position in shares of AptarGroup by 4,983.3% during the 2nd quarter. Versant Capital Management Inc now owns 305 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 299 shares during the period. 88.52% of the stock is currently owned by institutional investors and hedge funds.

About AptarGroup

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.